Literature DB >> 16800730

Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?

Olivia L Tan1, Astrid K Whitbread, Judith A Clements, Ying Dong.   

Abstract

The kallikrein-related peptidase (KLK) gene family of 15 serine proteases encodes many proteins, including prostate specific antigen (PSA or KLK3), that are well described and/or are potential biomarkers for hormone-related cancers. Variant mRNA transcripts produced by alternative splicing, polyadenylation or AUG sites, or intron retention have been found for each of the KLK genes. The predicted protein for many of these alternative transcripts is different from that of the classical kallikrein-related peptidases and would not be an active serine protease. The majority of these novel protein isoforms have not been studied in vivo. The possible function(s) of the variant transcripts/protein isoforms and potential roles that they may play in hormone-related cancers are still unknown and are the focus of this short review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800730     DOI: 10.1515/BC.2006.088

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2010-09-19       Impact factor: 2.957

2.  The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2009-12-02       Impact factor: 2.957

3.  Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.

Authors:  Akos Végvári; Melinda Rezeli; Charlotte Welinder; Johan Malm; Hans Lilja; György Marko-Varga; Thomas Laurell
Journal:  J Proteomics       Date:  2010-01-25       Impact factor: 4.044

4.  Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.

Authors:  Maroulio Talieri; Marina Devetzi; Andreas Scorilas; Eleana Pappa; Nikolaos Tsapralis; Ioannis Missitzis; Alexandros Ardavanis
Journal:  Tumour Biol       Date:  2012-02-21

5.  Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Constantina Petraki; Youssef M Youssef; William Dubinski; Zsuzsanna Lichner; Andreas Scorilas; Maria D Pasic; Vassilios Komborozos; Bishoy Khalil; Catherine Streutker; Eleftherios P Diamandis; George M Yousef
Journal:  Tumour Biol       Date:  2012-03-22

6.  A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.

Authors:  Jyotsna Batra; Christina M Nagle; Tracy O'Mara; Melanie Higgins; Ying Dong; Olivia L Tan; Felicity Lose; Lene Marie Skeie; Srilakshmi Srinivasan; Kelly L Bolton; Honglin Song; Susan J Ramus; Simon A Gayther; Paul D P Pharoah; Mary-Anne Kedda; Amanda B Spurdle; Judith A Clements
Journal:  BMC Cancer       Date:  2011-04-01       Impact factor: 4.430

7.  Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.

Authors:  Weiwei Gong; Yueyang Liu; Christof Seidl; Tobias Dreyer; Enken Drecoll; Matthias Kotzsch; Holger Bronger; Julia Dorn; Viktor Magdolen
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

8.  Computational analysis of splicing errors and mutations in human transcripts.

Authors:  Yerbol Z Kurmangaliyev; Mikhail S Gelfand
Journal:  BMC Genomics       Date:  2008-01-14       Impact factor: 3.969

Review 9.  Metastasis of ovarian cancer is mediated by kallikrein related peptidases.

Authors:  Ying Dong; Daniela Loessner; Helen Irving-Rodgers; Andreas Obermair; James L Nicklin; Judith A Clements
Journal:  Clin Exp Metastasis       Date:  2013-09-17       Impact factor: 5.150

10.  Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.

Authors:  Vassiliki Lila Koumandou; Andreas Scorilas
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.